Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Erdafitinib Tablets

Approval Number

国药准字HJ20250007

CompanyJANSSEN BIOTECH, INC.

Registration Date

January 8, 2025

Drug Information

Generic Name

厄达替尼片

Trade Name

博珂

Dosage Form

片剂

Strength

3mg

Drug Type

化学药品

Registration Date

January 8, 2025

Expiry Date

January 7, 2030

Company Information

Applicant Company

Company NameJANSSEN BIOTECH, INC.

Company Address

800/850 Ridgeview Drive, Horsham, PA 19044, United States of America

Manufacturing Company

Company NameJanssen-Cilag SpA

Company Address

Via C. Janssen, Borgo San Michele, 04100 Latina, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy